about
Acute migraine: Current treatment and emerging therapiesMigraine and risk of cardiovascular disease in women: prospective cohort studyEvolutionary biology and anthropology suggest biome reconstitution as a necessary approach toward dealing with immune disordersCalcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation.Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin.Discovery and Development of Calcium Channel Blockers.Migraine and the Mu-opioidergic system-Can we directly modulate it? Evidence from neuroimaging studies.IL-1β stimulates COX-2 dependent PGE₂ synthesis and CGRP release in rat trigeminal ganglia cells.The association of migraine with ischemic stroke.Evaluation of the changes in the nasal cavity during the migraine attack.Functional crosstalk in culture between macrophages and trigeminal sensory neurons of a mouse genetic model of migraineTNFα levels and macrophages expression reflect an inflammatory potential of trigeminal ganglia in a mouse model of familial hemiplegic migraineMigraine associated with gastrointestinal disorders: review of the literature and clinical implications.Epigenetic mechanisms in migraine: a promising avenue?Thickening in the somatosensory cortex of patients with migraine.Migraine pain, meningeal inflammation, and mast cells.C-reactive protein in migraine sufferers similar to that of non-migraineurs: the Reykjavik Study.The place of corticosteroids in migraine attack management: A 65-year systematic review with pooled analysis and critical appraisal.High sensitivity C-reactive protein and cerebral white matter hyperintensities on magnetic resonance imaging in migraine patients.What the Gut Can Teach Us About Migraine.Sensitization of dural afferents underlies migraine-related behavior following meningeal application of interleukin-6 (IL-6).Sex-, Stress-, and Sympathetic Post-Ganglionic Neuron-Dependent Changes in the Expression of Pro- and Anti-Inflammatory Mediators in Rat Dural Immune Cells.Mast cell degranulation activates a pain pathway underlying migraine headache.Comorbid neuropathologies in migraine: an update on cerebrovascular and cardiovascular aspects.Hypoxia facilitates neurogenic dural plasma protein extravasation in mice: a novel animal model for migraine pathophysiologyPerivascular nerves and the regulation of cerebrovascular tone.Polytherapy in the preventive and acute treatment of migraine: fundamentals for changing the approach.A combinational effect of acetaminophen and oriental herbs on the regulation of inflammatory mediators in microglia cell line, BV2Mast cell involvement in the pathophysiology of migraine headache: A hypothesis.Risk of Migraine in Patients With Asthma: A Nationwide Cohort Study.Migraine, depression, and brain volume: the AGES-Reykjavik StudyOestrogen increases nociception through ERK activation in the trigeminal ganglion: evidence for a peripheral mechanism of allodynia.pH-evoked dural afferent signaling is mediated by ASIC3 and is sensitized by mast cell mediators.The change of neutrophils/lymphocytes ratio in migraine attacks: A case-controlled study.Cutaneous allodynia and migraine: another view.Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology.CGRP and migraine: could PACAP play a role too?The potential impact of primary headache disorders on stroke risk.Neurovascular signaling in the brain and the pathological consequences of hypertension.Migraine pain and nociceptor activation--where do we stand?
P2860
Q24654649-665BE2FF-C879-4421-9365-0FF47FE89345Q24658645-A7B0886A-2D99-4E00-9F11-F30B22802C8DQ30048092-67EFE19C-CF95-4B3F-B26C-3DF791D56A77Q30466408-82A775FD-82E6-4BEE-9E35-520466B9EE2DQ33503623-3DE68F27-F182-4793-AB6A-84DD1886910BQ33734936-F3E6EB20-63FD-4108-A3DB-30A245B886E7Q33799032-C19552C2-517B-4C5F-9D44-93DEA8611025Q33843307-B6001429-2B4D-4585-8605-04D8573C3E30Q34112584-9A16A4A6-C878-430C-92E4-E389BB081F7FQ34167587-6E253AFF-21CA-47C6-A10C-82EE2F996548Q34484542-191977C9-D7E6-457A-9B1B-9DDCC7277009Q34550940-1838CC13-2876-40AF-A095-167490AA76B3Q34554827-151C18EC-3773-404C-9468-B2936BEAA7D2Q34573784-2800A6F7-A89C-4138-81B9-E1948699126CQ34715344-532DDC50-CD15-4AE6-BDC6-5AD54EFBC097Q34982088-61C65767-124E-43CD-A48D-3EE02D8AF9B7Q35098217-0B4A3D47-986C-4E42-869D-6FB180AD922BQ35541053-C3311B69-B953-4CE8-BAA4-135F081D9B16Q35561925-255BDE6D-C63F-4937-9BBF-DFD4D084E67BQ35655397-71B81F9A-EB11-4AFE-9458-AF99CEF86A9CQ35742243-DC272E5D-41CC-4D61-BE1F-DE005C781147Q35888199-FCDFE48C-0085-4ED6-9ED2-03D0F95D6A31Q36098310-CEA4DB23-F7E7-4E5F-8305-4FE6AFAC35FEQ36260205-F1B10C64-B2BF-4152-8875-BBF8242BB781Q36353546-5F2ABEE7-A8B8-46DD-814D-23FBC970400BQ36391631-2AD98569-C459-46E7-9BED-00530617703DQ36419543-17ACCD22-EAC1-4AFE-86A3-9A29FE433574Q36431202-CCD84AB8-0A4F-46E0-981B-B15791249340Q36574907-30D5237E-2451-482B-B0FE-DDCBB97599AEQ36663974-8E1D1D44-92A1-4254-8A36-83EF76013DC5Q37027167-7CE9544D-848D-4020-8BFC-8F053BAA8297Q37165097-6BFC63D0-829D-4A3E-B6E9-76CC8F35BC05Q37170692-2DBDB9F4-901A-4F10-999E-0F9CEEFE9615Q37172630-BA8580FE-06C3-4B55-AA06-17098A979338Q37263436-CE0BCB01-FAFF-48A2-A445-CF9A0EDCD21AQ37318028-C51182EE-051C-4C04-93DE-7D2C84EB57B0Q37384128-68716B0F-22D0-44B8-98D8-30646692C6C2Q37459128-D39F0CC8-0B80-4C0C-A4D2-0662B6EEECFEQ37575941-62740AE0-86D0-4BB7-A01B-983ADC79261BQ37764954-58A04B7B-05D9-424D-8E8D-25E5DFD8C2EF
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Migraine as an inflammatory disorder.
@ast
Migraine as an inflammatory disorder.
@en
type
label
Migraine as an inflammatory disorder.
@ast
Migraine as an inflammatory disorder.
@en
prefLabel
Migraine as an inflammatory disorder.
@ast
Migraine as an inflammatory disorder.
@en
P1433
P1476
Migraine as an inflammatory disorder.
@en
P2093
Michael A Moskowitz
P356
10.1212/WNL.64.10_SUPPL_2.S9
P407
P433
10 Suppl 2
P577
2005-05-01T00:00:00Z